SFI
EVH icon

Susquehanna Fundamental Investments’s Evolent Health EVH Stock Holding History

Susquehanna Fundamental Investments’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-127,173
Closed -$4.57M – 1281
2022
Q3 		$4.57M Buy
+127,173
New +$4.48M 0.08% 340
2021
Q4 		– Sell
-10,515
Closed -$326K – 1536
2021
Q3 		$326K Sell
10,515
-26,400
-72% -$634K 0.01% 1376
2021
Q2 		$780K Sell
36,915
-66,000
-64% -$1.32M 0.01% 967
2021
Q1 		$2.08M Hold
102,915
– – 0.04% 632
2020
Q4 		$1.65M Buy
102,915
+10,515
+11% +$139K 0.03% 682
2020
Q3 		$1.15M Buy
92,400
+8,800
+11% +$103K 0.03% 591
2020
Q2 		$595K Buy
+83,600
New +$560K 0.03% 565

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Susquehanna Fundamental Investments's EVH Position: Q4 2022 in Review

Susquehanna Fundamental Investments sold out of Evolent Health (EVH) in Q4 2022, closing a stake of 127,173 shares — an estimated $4.57M sold.

Susquehanna Fundamental Investments first reported a position in EVH in Q2 2020 and held it in 7 quarters. The position peaked at $4.57M in Q3 2022. 232 funds tracked by Wall St. Rank hold EVH as of Q4 2022.

  • Susquehanna Fundamental Investments reported no remaining Evolent Health position as of Q4 2022 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 127,173 Evolent Health shares in Q4 2022, an estimated $4.57M.
  • Susquehanna Fundamental Investments first reported a position in Evolent Health in Q2 2020 and held it in 7 quarters.
  • Susquehanna Fundamental Investments's Evolent Health position peaked at $4.57M in Q3 2022.
  • 232 funds tracked by Wall St. Rank held Evolent Health as of Q4 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2022, filed 14 Feb 2023.